PET Using Prostate-Specific Ligand Accurately Localizes Recurrent Prostate Cancer PET Using Prostate-Specific Ligand Accurately Localizes Recurrent Prostate Cancer

PET using a gallium-labeled prostate-specific membrane antigen (68Ga-PSMA-11) as ligand accurately localizes recurrent prostate cancer, according to a new prospective study.Reuters Health Information
Source: Medscape Radiology Headlines - Category: Radiology Tags: Hematology-Oncology News Source Type: news